在血液传播的转移中,CBX3赋予铁灭菌耐药性
Chun Wu1,2, Xuefei Liu1,3, Boxi Zhao1
1Department of Biochemistry School of Medicine, SUSTech Homeostatic Medicine Institute Southern University of Science and Technology, Shenzhen, 518055, Guangdong, China.
Journal of hematology & oncology
|January 16, 2026
概括
循环瘤细胞 (CTC) 通过上调染色盒3 (CBX3) 来抵抗细胞死亡途径铁亡. 这种耐药性对于肺腺癌 (LUAD) 转移和患者存活至关重要.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 循环瘤细胞 (CTC) 是癌症转移的关键,但它们的生存机制尚不清楚.
- 了解CTC生存率对于开发针对转移性疾病的向疗法至关重要.
研究的目的:
- 阐明CTC在过境和殖民期间的生存机制.
- 确定特定的分子途径和因素,使CTC存活并促进肺腺癌 (LUAD) 的转移.
主要方法:
- 微流体丰富的CTC和匹配的大脑转移性瘤细胞的单细胞RNA测序 (scRNA-seq).
- 使用转录基因组和全外体组测序进行比较基因组不稳定性和拷贝数变异 (CNV) 分析.
- 功能性研究涉及癌细胞模型中关键识别基因 (CBX3) 的遗传枯竭和过度表达.
主要成果:
- CTCs表现出与耐铁灭症相关的基因特征的上调.
- 染色体3 (CBX3) 被确定为一个关键的转录因子,通过升调GPX4.4来保护CTC免受铁亡.
- CBX3的枯竭会减少瘤细胞的存活和侵入性,而其过度表达会促进瘤的生长,迁移,入侵和转移.
- 在CTC中增加CBX3和GPX4表达与转移性LUAD相关,并预测患者的治疗结果不佳.
结论:
- CTC采用由CBX3驱动的铁灭抵抗机制,以生存循环并促进转移.
- 在LUAD中,CBX3是抑制CTC存活和预防转移性进展的潜在治疗标.
- 在CTC中CBX3和GPX4的共同表达作为转移性疾病和患者预后的生物标志物.
相关概念视频
00:57Antibiotic Selection
Overview
01:31Defense Against Bacterial Pathogens
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
01:16Transduction
Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome are...
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...